Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry.

Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB.

Brain Behav. 2019 Nov;9(11):e01422. doi: 10.1002/brb3.1422. Epub 2019 Oct 4.

2.

Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study.

Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø.

Mult Scler. 2019 Oct 1:1352458519877244. doi: 10.1177/1352458519877244. [Epub ahead of print]

PMID:
31573834
3.

The economic impact of multiple sclerosis to the patients and their families in Norway.

Svendsen B, Grytten N, Bø L, Aarseth H, Smedal T, Myhr KM.

Eur J Health Econ. 2018 Dec;19(9):1243-1257. doi: 10.1007/s10198-018-0971-5. Epub 2018 Apr 21.

PMID:
29680926
4.

Survival in multiple sclerosis: things have changed.

Grytten N.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):618. doi: 10.1136/jnnp-2017-316210. No abstract available.

PMID:
28705950
5.

Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.

Lunde HMB, Assmus J, Myhr KM, Bø L, Grytten N.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):621-625. doi: 10.1136/jnnp-2016-315238. Epub 2017 Apr 1.

6.

The influence of coping styles on long-term employment in multiple sclerosis: A prospective study.

Grytten N, Skår AB, Aarseth JH, Assmus J, Farbu E, Lode K, Nyland HI, Smedal T, Myhr KM.

Mult Scler. 2017 Jun;23(7):1008-1017. doi: 10.1177/1352458516667240. Epub 2016 Sep 6.

PMID:
27600114
7.

Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom.

Cortese M, Riise T, Bjørnevik K, Bhan A, Farbu E, Grytten N, Hogenesch I, Midgard R, Smith Simonsen C, Telstad W, Ascherio A, Myhr KM.

Ann Neurol. 2016 Oct;80(4):616-24. doi: 10.1002/ana.24769.

PMID:
27554176
8.

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.

Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Torkildsen Ø, Vatne A, Grytten N.

Mult Scler. 2017 Feb;23(2):213-219. doi: 10.1177/1352458516646863. Epub 2016 Jul 11.

9.

Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.

Grytten N, Torkildsen Ø, Myhr KM.

Acta Neurol Scand. 2015 Nov;132(5):368-9. doi: 10.1111/ane.12488. Epub 2015 Sep 15. No abstract available.

PMID:
26369381
10.

Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.

Grytten N, Torkildsen Ø, Myhr KM.

Acta Neurol Scand. 2015;132(199):29-36. doi: 10.1111/ane.12428. Review.

11.

The Norwegian Multiple Sclerosis Registry and Biobank.

Myhr KM, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Aarseth JH.

Acta Neurol Scand. 2015;132(199):24-8. doi: 10.1111/ane.12427. Review.

PMID:
26046555
12.

A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.

Grytten N, Aarseth JH, Lunde HM, Myhr KM.

J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):100-5. doi: 10.1136/jnnp-2014-309906. Epub 2015 Feb 24.

13.

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.

Torkildsen O, Aarseth J, Celius EG, Holmøy T, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Riise T, Grytten N.

Ann Clin Transl Neurol. 2014 May;1(5):376-7. doi: 10.1002/acn3.56. Epub 2014 Apr 10. No abstract available.

14.

Month of birth and risk of multiple sclerosis: confounding and adjustments.

Torkildsen O, Aarseth J, Benjaminsen E, Celius E, Holmøy T, Kampman MT, Løken-Amsrud K, Midgard R, Myhr KM, Riise T, Grytten N.

Ann Clin Transl Neurol. 2014 Feb;1(2):141-4. doi: 10.1002/acn3.37. Epub 2014 Feb 4.

15.

Employment among patients with multiple sclerosis-a population study.

Bøe Lunde HM, Telstad W, Grytten N, Kyte L, Aarseth J, Myhr KM, Bø L.

PLoS One. 2014 Jul 23;9(7):e103317. doi: 10.1371/journal.pone.0103317. eCollection 2014.

16.

"I refer to them as my colleagues": the experience of mutual recognition of self, identity and empowerment in multiple sclerosis.

Skår AB, Folkestad H, Smedal T, Grytten N.

Disabil Rehabil. 2014;36(8):672-7. doi: 10.3109/09638288.2013.808273. Epub 2013 Jul 26.

PMID:
23889526
17.

Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.

Kampman MT, Aarseth JH, Grytten N, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Torkildsen O.

J Neurol. 2013 Jun;260(6):1481-8. doi: 10.1007/s00415-012-6814-x. Epub 2013 Jan 6.

PMID:
23292231
18.

Month of birth as a risk factor for multiple sclerosis: an update.

Torkildsen O, Grytten N, Aarseth J, Myhr KM, Kampman MT.

Acta Neurol Scand Suppl. 2012;(195):58-62. doi: 10.1111/ane.12040.

PMID:
23278658
19.

Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis--a multicentre cohort study.

Grytten N, Aarseth JH, Espeset K, Berg Johnsen G, Wehus R, Lund C, Riise T, Haugstad R.

Acta Neurol Scand Suppl. 2012;(195):51-7. doi: 10.1111/ane.12033.

PMID:
23278657
20.

The Norwegian Multiple Sclerosis Registry and Biobank.

Myhr KM, Grytten N, Aarseth JH.

Acta Neurol Scand Suppl. 2012;(195):20-3. doi: 10.1111/ane.12030.

PMID:
23278652
21.

A need for national registries and international collaborative research in multiple sclerosis.

Myhr KM, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Pugliatti M, Aarseth JH.

Acta Neurol Scand Suppl. 2012;(195):1-3. doi: 10.1111/ane.12039.

PMID:
23278648
22.

Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.

Grytten N, Torkildsen Ø, Aarseth JH, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Kampman MT.

Mult Scler. 2013 Jul;19(8):1028-34. doi: 10.1177/1352458512471094. Epub 2012 Dec 20.

PMID:
23257620
23.

Stoppers and non-starters of disease-modifying treatment in multiple sclerosis.

Grytten N, Aarseth JH, Espeset K, Johnsen GB, Wehus R, Lund C, Haugstad RC.

Acta Neurol Scand. 2013 Feb;127(2):133-40. doi: 10.1111/j.1600-0404.2012.01708.x. Epub 2012 Aug 25.

PMID:
22924678
24.

Immunomodulatory treatment of multiple sclerosis in Norway.

Torkildsen Ø, Grytten N, Myhr KM.

Acta Neurol Scand Suppl. 2007;187:46-50.

PMID:
17419828
26.
27.
28.

A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.

Grytten N, Glad SB, Aarseth JH, Nyland H, Midgard R, Myhr KM.

Neurology. 2006 Jan 24;66(2):182-6.

PMID:
16434650
29.

[Physicians and social security].

Grytten NJ.

Tidsskr Nor Laegeforen. 1997 Apr 10;117(9):1323-5. Norwegian. No abstract available.

PMID:
9182366

Supplemental Content

Loading ...
Support Center